<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731209</url>
  </required_header>
  <id_info>
    <org_study_id>0308-15-ASF</org_study_id>
    <nct_id>NCT02731209</nct_id>
  </id_info>
  <brief_title>Functional Urodynamic Changes in Chronic Kidney Disease Patients and Does Insertion of Urinary Catheter Delay the Need for Kidney Dialysis</brief_title>
  <official_title>Functional Urodynamic Changes in Chronic Kidney Disease Patients and Does Insertion of Urinary Catheter in Chronic Kidney Disease Patients Grade 4 Delay the Need for Kidney Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assaf Harofeh MC</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assaf-Harofeh Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the investigators work is to describe the urodynamic results in the CKD (chronic
      kidney disease) grade 4 patients and to verify observations that urinary catheter may improve
      kidney function in those patients.

      100 patients with CKD grade 4 will do urodynamic examination.

      All patients will be randomized into two groups / the intervention group that will be
      inserted urinary catheter for 2 weeks and the follow up group. Kidney function will be
      monitored by creatinin values and the investigators will measure the time to dialysis in the
      two groups.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>kidney function change</measure>
    <time_frame>At the time of urinary catheter insertion. Two weeks from the insertion and than after 8,16, 24, 32, 40 and 48 weeks after the urinary catheter insertion. (at total 52 weeks of follow up)</time_frame>
    <description>measured by creatinine values mg/dL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to dialysis</measure>
    <time_frame>at least 1 year from the time of catheter insertion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>catheter insertion for 2 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 randomized patients that will do urodynamic urinary examination and will be inserted urinary catheter for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>follow up</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>50 randomized patients that will do urodynamic urinary examination and will be regularly followed by nephrologist</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>urinary catheter</intervention_name>
    <arm_group_label>catheter insertion for 2 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18

          -  chronic kidney disease grade 4-5 (eGFR (estimated glomerular filtration rate) &lt;30)

          -  eligible to sign a consent form

        Exclusion Criteria:

          -  non controlled Diabetes Melitus (HbA1C&gt;10%)

          -  not controlled HTN (Hypertension)

          -  cardiovascular event requiring cardiac stenting

          -  renal hydronephrosis or post void rest &gt; 200CC according to US (Ultrasound)

          -  acute renal failure

          -  not eligible for urodynamics for any reason

          -  constant urinary catheter for any reason
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Asaf ha Rofeh, MC</name>
      <address>
        <city>Zrifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilya Baberashvili, Doctor of Medicine</last_name>
      <phone>+972537346133</phone>
      <email>iliav@asaf.health.gov.il</email>
    </contact>
    <contact_backup>
      <last_name>Guy Verhovsky, MD</last_name>
      <phone>+972548137811</phone>
      <email>guy.verchovsky@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ilya Baberashvili, Doctor of Medicine</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2016</study_first_submitted>
  <study_first_submitted_qc>April 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2016</study_first_posted>
  <last_update_submitted>April 2, 2016</last_update_submitted>
  <last_update_submitted_qc>April 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Assaf-Harofeh Medical Center</investigator_affiliation>
    <investigator_full_name>Assaf Harofeh MC</investigator_full_name>
    <investigator_title>Medical doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

